From Ore to Gold Bars-This Nevada Mine Is Already Producing

Most juniors explore...Few actually produce. This one's already pouring gold thanks to infrastructure that would cost tens of millions to build today. With major land holdings and room to scale, it's one to watch. Discover the little known gold company that's already producing.

BMRN
Biomarin Pharmaceutical Inc
NASDAQ
54.01
Open 53.24 Prev Close 53.14
High 54.42 Low 53.15
Volume 1,519,966 Volume (Avg) 2,116
52 Week High 73.51 52 Week Low 52.93
Market Cap 10.4B PE Ratio 16.00

About Biomarin Pharmaceutical Inc

BioMarin Pharmaceutical Inc., a biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally. The company's products include VIMIZIM, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; VOXZOGO, a once daily injection analog of c-type natriuretic peptide (CNP) for the treatment of achondroplasia; NAGLAZYME, a recombinant form of N- acetylgalactosamine 4-sulfatase for patients with MPS VI; and PALYNZIQ, a PEGylated recombinant phenylalanine (Phe) ammonia lyase enzyme delivered through subcutaneous injection to reduce blood Phe concentrations. It also develops BRINEURA, a recombinant human tripeptidyl peptidase 1 for the treatment of patients with ceroid lipofuscinosis type 2, a form of Batten disease; ALDURAZYME, a purified protein designed to be identical to a naturally occurring form of the human enzyme alpha-L-iduronidase; KUVAN, a proprietary synthetic oral form of 6R-BH4 that is used to treat patients with phenylketonuria, an inherited metabolic disease; and ROCTAVIAN, an adeno associated virus vector for the treatment of severe hemophilia A. The company's products under development include BMN 333, a longer-acting CNP for the treatment of multiple growth disorders, such as achondroplasia and hypochondroplasia; BMN 349, an oral therapeutic for the treatment of liver disease associated with alpha-1 antitrypsin deficiency; and BMN 351, an oligonucleotide for the treatment of duchenne muscular dystrophy. It serves specialty pharmacies, hospitals, non-U.S. government agencies, distributors, and pharmaceutical wholesalers. The company has license and collaboration agreements with Catalyst Pharmaceutical Partners, Inc., and Ares Trading S.A. The company was incorporated in 1996 and is based in San Rafael, California.

General

NameBiomarin Pharmaceutical Inc
TickerBMRN
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees3,040

Highlights

Analyst Target97.12
Market Cap10,371,700,000
PE Ratio16.00
PEG Ratio0.62
EBITDA955,153,024

Share Stats

Shares Outstanding192,000,000
Shares Float189,120,000
Shares Short5,960,000
Insider Holdings78%
Institution Holdings98.97%

Highlights

Analyst Target97.12
Market Cap10,371,700,000
PE Ratio16.00
PEG Ratio0.62
EBITDA955,153,024

Valuation

Trailing PE15.96
Forward PE10.55
Price/Sales (Trailing 12 Mt.)3.39
Price/Book (Most Recent Quarter)1.72

Earnings

Most Popular

Jim Cramer Recommends Buying This Industrial Stock, Calling It 'Way Too Cheap'

"Mad Money" star Jim Cramer discusses MP Materials, Resideo Technologies and Canadian National Railway on Friday, Sept. 12.

Bill Ackman Has 70% Of His Portfolio Invested In These 5 Stocks: Here's What Q2 13F Filings Show

Discover how Bill Ackman invested ~70% of his $13.7M portfolio in 5 stocks like UBER & AMZN per Q2 2025 13F filings. Explore top holdings now!

The $25M Contract Nobody Is Talking About - Ad

One deal alone covers the entire valuation of this overlooked stock. And more contracts are already stacking up in Europe and the US.

Powerball Jackpot Soars To $1.1 Billion After No Winning Tickets, 5th Largest In History

The Powerball jackpot has reached $1.1 billion after no winner in Saturday's drawing, with nine tickets earning $1 million.

Jim Cramer Expects Palantir To Reach New All-Time High

Market analysts and financial commentators provide crucial guidance in the volatile investment landscape. Cramer says no to VKTX, but expects PLTR to go up.

The Next Palantir Moment Could Be Here - Ad

A $21M market cap company is landing multimillion-dollar contracts with banks and governments. With only 9.7M shares in the float, scarcity could spark explosive moves.

BrilliA Inc Soars Over 87% After Hours Following Cash Dividend Announcement

BrilliA Inc. shares soared 86.73% in after-hours trading Wednesday after announcing a cash dividend.

Is This Elon's Worst Nightmare? - Ad

Elon's empire looks doomed - crashing sales, lost tax credits, and media backlash. But behind the scenes, Tesla is about to unleash a breakthrough Forbes calls a "multi-trillion-dollar opportunity." It's not the end - it's the start of a 25,000% AI comeback.

Koch family agrees to buy a 10% stake in the NFL's New York Giants, AP source says

The Koch family has agreed to purchase a 10% stake of the NFL's New York Giants, according to a person familiar with the deal.

US media quickly forced to revisit a thorny question: How should a president's health be covered?

Early in Donald Trump's Tuesday, Fox News' Peter Doocy asked a question that surely baffled people who avoided social media for Labor Day.

The Roadmap to $100M+ Revenue - Ad

Recurring deals, Tier-1 banks, and expansion into new markets put this company on track to triple revenue by 2026. Yet the market cap is still just $21M.

Nestlé dismisses CEO due to an inappropriate relationship with a subordinate

Swiss food giant Nestlé said Monday it dismissed its CEO Laurent Freixe due to an inappropriate relationship with a subordinate.

Bondi Fires DOJ Employee Over Alleged Gesture Toward Guard Troops

AG Pam Bondi fired a DOJ paralegal for allegedly flipping off National Guard troops in D.C., underscoring tensions around Trump's federal crime crackdown.

Gold Alert: Extraordinary Upside in One Stock (Not a Miner) - Ad

Gold has hit all-time highs, breaking $3,600 an ounce - but history shows it could be on the verge of its biggest bull run in over half a century... triggered by a likely major event, eerily similar to what happened in the 1970s. (It's NOT inflation or anything you're likely expecting.) Now, a top analyst says you can capture ALL of the upside without touching a risky miner or a boring exchange-traded fund. He sees extraordinary potential gains long term with very little risk.

Social Security whistleblower who claims DOGE mishandled Americans' sensitive data resigns from post

WASHINGTON (AP) — A Social Security official who has filed a whistleblower complaint alleging the Department of Government Efficiency officials Americans' sensitive information says he's resigning his post because of actions taken against him since making his complaint.

Robinhood Stock Surges Over 7% In Monday Pre-Market: What's Going On?

The stock of Robinhood Markets Inc. (NASDAQ: HOOD) surged 7.46% during the Monday pre-market trading session following Friday's news that it will be included in the S&P 500.

Analysts Project This Stock Could Jump to $14 a Share. You Can Still Invest for $3.50. - Ad

The AI company making heart disease easier to detect is offering investors $3.50 investment units that include one convertible preferred share and one warrant, providing investors with access to 2 common shares. Based on analyst 1- year projections, that amounts to a near-term 500% return potential.

Third Richest Woman In The World Eyes New York Giants Stake For Future Growth

One of the richest women in the world could have her eyes on more sports team ownership with a stake in the New York Giants.

Inside Warren Buffett's Decision to Keep Leading Berkshire Hathaway in His 90s

Warren Buffett's retirement decision has sparked debates about his reasons for working past the typical retirement age and his current choice to step aside.

Why Are Wall Street Insiders Moving Their Money to This One Asset? - Ad

Something far more consequential for your money than tariffs is unfolding behind the scenes... Tucked inside this overlooked directive is a plan set to be executed for the first time in in U.S. history. One Stansberry Research's Senior Partner says it's set to trigger a rare window for potentially explosive gains in ONE asset immediately. (Not AI or crypto). Wall Street insiders are already positioning themselves... and he insists you should, too, before it's too late.

Elon Musk's Legal Team Fights To Block OpenAI's Access To Meta's Bid Documents

Elon Musk's legal team has filed a motion to prevent OpenAI from obtaining documents related to a previous $97.4 billion bid for its assets, according to a court filings.

South Korea president says Korean companies will hesitate to invest in US without better visa system

SEOUL, South Korea (AP) — South Korea’s president said Thursday that South Korean companies will likely hesitate to maintain or make direct investments in the United States if the U.S. fails to for Korean workers.

Scarcity Meets Momentum - Ad

With insiders and institutions holding most of the float, just 9.7M shares are truly available. New contracts could ignite moves that Wall Street can't ignore.

Skye Bioscience Advances Position In Competitive Obesity Market With Promising Data

Skye Bioscience's latest data show nimacimab boosted tirzepatide's weight loss effects and reduced obesity treatment rebound risk.

Opendoor Is A 'Stock That Could Be The Amazon Of Housing': Eric Jackson

Eric Jackson sees Opendoor as able to simplify the experience of buying and selling a home in the same way that Amazon revolutionized retail.

This Gold Miner Has the Map, the Metal, and the Momentum - Ad

JPMorgan is forecasting that gold will push past $4,000, and this Nevada operation is positioned to benefit. Historical estimates show its property could hold around 1.8 million ounces of measured and indicated gold, backed by infrastructure and billionaire investors. The company's already producing, refining gold onsite and looking to expand. That's not a dream-stage story-that's a head start.

China's export growth slows in August amid trade tensions with US

BEIJING (AP) — grew last month but at a slower pace than in recent months, the country's customs agency said Monday.

Trump's Tariffs, Wall Street's Fear Gauge And A Veteran Economist's Dire Warning: This Week In Economy

Markets kicked off September on shaky ground as tariffs, weak jobs data, and warnings of a global collapse rattled investor confidence and fueled volatility.

From Ore to Gold Bars-This Nevada Mine Is Already Producing - Ad

Most juniors explore...Few actually produce. This one's already pouring gold thanks to infrastructure that would cost tens of millions to build today. With major land holdings and room to scale, it's one to watch. Discover the little known gold company that's already producing.

Toyota Reshapes US Strategy: More Hybrids, New EVs, Fewer Lexus Sedans

Toyota Motor shares are trading lower on Wednesday after Reuters reported that the carmaker was adjusting its U.S. manufacturing footprint.

NIO Investors Rattled As EV Maker Issues Massive Equity Offering

NIO shares fell after announcing plans for equity offering to fund R&D, new models, and infrastructure. Q2 results show strong growth, but profitability still a challenge.

The $25M Contract Nobody Is Talking About - Ad

One deal alone covers the entire valuation of this overlooked stock. And more contracts are already stacking up in Europe and the US.

The Next Palantir Moment Could Be Here - Ad

A $21M market cap company is landing multimillion-dollar contracts with banks and governments. With only 9.7M shares in the float, scarcity could spark explosive moves.

South Korean workers detained in immigration raid headed to Atlanta for flight home

ATLANTA (AP) — Buses carrying workers from South Korea who were detained last week in an immigration raid at a battery factory were traveling Thursday from a detention center in southeast Georgia to Atlanta, where a charter plane was waiting to take them home.

Elon Musk in line for $1 trillion pay package if Tesla hits aggressive goals over next 10 years

could be in line for a payout of $1 trillion if his electric car company meets a series of extremely aggressive targets over the next 10 years, according to documents released by the company.

Is This Elon's Worst Nightmare? - Ad

Elon's empire looks doomed - crashing sales, lost tax credits, and media backlash. But behind the scenes, Tesla is about to unleash a breakthrough Forbes calls a "multi-trillion-dollar opportunity." It's not the end - it's the start of a 25,000% AI comeback.

AI Bull Market Fuels A Wave Of New Listings: 3 IPO ETFs In Focus

IPO-ETFs like IPO, FPX and FPXI are in focus as the U.S. market sees its fastest rebound since 2021, fueled by the AI boom and $23B raised year-to-date.

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright systemtrading.ca
Privacy Policy | Terms of Service